Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for 2019 (699 publications)

no pagination
Gutierrez-Diez PJ, Lopez-Marcos MA, Martinez-Rodriguez J, Russo J. The effects of time valuation in cancer optimal therapies: a study of chronic myeloid leukemia. Theoretical biology & medical modelling. 2019 May 28;16(1):10.   PMCID: PMC6540446
Doss M. Comment on 'Implications of recent epidemiologic studies for the linear nonthreshold model and radiation protection'. Journal of radiological protection : official journal of the Society for Radiological Protection. 2019 May 24;39(2):650-4.   PMCID: Commentary
Reilly SW, Riad AA, Hsieh CJ, Sahlholm K, Jacome DA, Griffin S, Taylor M, Weng CC, Xu K, Kirschner N, Luedtke RR, Parry C, Malhotra S, Karanicolas J, Mach RH. Leveraging a Low-Affinity Diazaspiro Orthosteric Fragment to Reduce Dopamine D 3 Receptor (D 3 R) Ligand Promiscuity across Highly Conserved Aminergic G-Protein-Coupled Receptors (GPCRs). Journal of medicinal chemistry. 2019 May 23;62(10):5132-47.
Sykes SM. NCAM1 supports therapy resistance and LSC function in AML. Blood. 2019 May 23;133(21):2247-8.
Papatla K, Halpern MT, Hernandez E, Brown J, Benrubi D, Houck K, Chu C, Rubin S. Second primary anal and oropharyngeal cancers in cervical cancer survivors. American journal of obstetrics and gynecology. 2019 May 22;221(5):478 e1-478 e6.
Bretthauer M, Kalager M, Weinberg DS. From Colorectal Cancer Screening Guidelines to Headlines: Beware!. Annals of internal medicine. 2019 May 21;170(10):734.
Ogunwobi OO, Harricharran T, Huaman J, Galuza A, Odumuwagun O, Tan Y, Ma GX, Nguyen MT. Mechanisms of hepatocellular carcinoma progression. World journal of gastroenterology. 2019 May 21;25(19):2279-93.   PMCID: PMC6529884
Younes A, Sehn LH, Johnson P, Zinzani PL, Hong XN, Zhu J, Patti C, Belada D, Samoilova O, Suh C, Leppa S, Rai S, Turgut M, Jurczak W, Cheung MC, Gurion R, Yeh SP, Lopez-Hernandez A, Duhrsen U, Thieblemont C, Chiattone CS, Balasubramanian S, Carey J, Liu G, Shreeve SM, Sun S, Zhuang SH, Vermeulen J, Staudt LM, Wilson W, Fisher RI, Engert A, Stadtmauer EA, Wei LJ, Phoenix Investigators. Randomized Phase III Trial of Ibrutinib and Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Non-Germinal Center B-Cell Diffuse Large B-Cell Lymphoma. J Clin Oncol. 2019 May 20;37(15):1285-95.   PMCID: PMC6553835
Bartel MJ, Higa JT, Tokar JL. The Status of SEMS Versus Plastic Stents for Benign Biliary Strictures. Current gastroenterology reports. 2019 May 16;21(7):29.
Liu JC, Kaplon A, Blackman E, Miyamoto C, Savior D, Ragin C. The impact of the multidisciplinary tumor board on head and neck cancer outcomes. The Laryngoscope. 2019 May 16;.
Zhang T, Balachandran S. Bayonets over bombs: RIPK3 and MLKL restrict Listeria without triggering necroptosis. The Journal of cell biology. 2019 May 16;218(6):1773-5.   PMCID: Commentary
Ghatalia P, Zibelman M, Geynisman DM, Plimack ER. First-line Immunotherapy in Metastatic Urothelial Carcinoma. European urology focus. 2019 May 15;.
Goel N, Nadler A, Reddy S, Hoffman JP, Pitt HA. Biliary microbiome in pancreatic cancer: alterations with neoadjuvant therapy. HPB : the official journal of the International Hepato Pancreato Biliary Association. 2019 May 14;21(12):1753-60.
Ishii Y, Yamamoto N, Matubayasi N, Zhang BW, Cui D, Levy RM. Spatially-Decomposed Free Energy of Solvation Based on the Endpoint Density-Functional Method. J Chem Theory Comput. 2019 May 14;15(5):2896-912.   PMCID: PMC6570404
Ji Y, Fioravanti J, Zhu W, Wang H, Wu T, Hu J, Lacey NE, Gautam S, Le Gall JB, Yang X, Hocker JD, Escobar TM, He S, Dell'Orso S, Hawk NV, Kapoor V, Telford WG, Di Croce L, Muljo SA, Zhang Y, Sartorelli V, Gattinoni L. miR-155 harnesses Phf19 to potentiate cancer immunotherapy through epigenetic reprogramming of CD8(+) T cell fate. Nat Commun. 2019 May 14;10(1):2157.   PMCID: PMC6517388
Thomas C, Ji Y, Wu C, Datz H, Boyle C, MacLeod B, Patel S, Ampofo M, Currie M, Harbin J, Pechenkina K, Lodhi N, Johnson SJ, Tulin AV. Hit and run versus long-term activation of PARP-1 by its different domains fine-tunes nuclear processes. Proc Natl Acad Sci U S A. 2019 May 14;116(20):9941-6.   PMCID: PMC6525528
Rosenthal SA, Hu C, Sartor O, Gomella LG, Amin MB, Purdy J, Michalski JM, Garzotto MG, Pervez N, Balogh AG, Rodrigues GB, Souhami L, Reaume MN, Williams SG, Hannan R, Horwitz EM, Raben A, Peters CA, Feng FY, Shipley WU, Sandler HM. Effect of Chemotherapy With Docetaxel With Androgen Suppression and Radiotherapy for Localized High-Risk Prostate Cancer: The Randomized Phase III NRG Oncology RTOG 0521 Trial. J Clin Oncol. 2019 May 10;37(14):1159-68.   PMCID: PMC6506419
Wissler HL, Ehlerding EB, Lyu Z, Zhao Y, Zhang S, Eshraghi A, Buuh ZY, McGuth JC, Guan Y, Engle JW, Bartlett SJ, Voelz VA, Cai W, Wang RE. Site-Specific Immuno-PET Tracer to Image PD-L1. Molecular pharmaceutics. 2019 May 06;16(5):2028-36.   PMCID: PMC6521698
Nicolas E, Tricarico R, Savage M, Golemis EA, Hall MJ. Disease-Associated Genetic Variation in Human Mitochondrial Protein Import. American journal of human genetics. 2019 May 02;104(5):784-801.   PMCID: PMC6506819
Ackroyd SA, Goetsch L, Brown J, Houck K, Wang C, Hernandez E. Pancreaticobiliary metastasis presenting as primary mucinous ovarian neoplasm: A systematic literature review. Gynecologic oncology reports. 2019 May;28:109-15.   PMCID: PMC6453658
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications for the year 2019


Last updated on Friday, January 03, 2020